joi, 8 decembrie 2011

Lipid-Modifying Enzyme: New Target For Pan-Viral Therapeutics

Main Category: Infectious Diseases / Bacteria / Viruses
Also Included In: Liver Disease / Hepatitis
Article Date: 08 Dec 2011 - 2:00 PST

email icon email to a friend   printer icon printer friendly   write icon opinions  
not yet ratednot yet rated
Three different disease-causing viruses -- poliovirus, coxsackievirus, and hepatitis C -- rely on their unwilling host for the membrane platforms enriched in a specific lipid, phosphatidylinositol 4 phosphate (PI4P) on which they can replicate, Rutgers University researchers said on Dec. 7, at the American Society for Cell Biology annual meeting in Denver.

The viruses carry proteins that enable them to gain access to the P14P lipid for replication. The proteins snare one of the host's own lipid-modifying enzymes, a Type III PI4-kinase (PI4-kinase), reported Nihal Altan-Bonnet, Ph.D., of Rutgers University.

The PI4-kinase may prove to be an excellent target for panviral therapeutics, Altan-Bonnet said. When the Rutgers researchers blocked this PI4-kinase, the invading viruses all ceased replicating, and their host cells survived.

The Rutgers group has extended its investigations to identify other viruses that might be vulnerable to this countermeasure.

Blocking the PI4-kinase was effective, Altan-Bonnet explained, because invading viruses require this enzyme to manufacture the P14P lipid for the platforms that they must set up on the host's membrane-bound organelles, which include the Golgi apparatus and the mitochondria.

The viruses can replicate only on cell membrane platforms enriched with the P14P lipid. To gain access to the lipid, the viruses employ a protein that hijacks the cell's P14-kinase.

They then use it to generate the lipid that enriches the platform. Once established, the viruses rapidly make copies of themselves that go on to infect other cells in the organism.

In normal, uninfected cells, the level of PI4P lipid on organelle membranes is generally low and increases only when signaling and membrane-remodeling proteins are required by the cell, said Altan-Bonnet.

But in infected cells, levels of PI4P lipid dramatically increase, reflecting the viruses' need for more PI4P lipid-enriched membrane surface to anchor their replication machinery.

Altan-Bonnet's lab also found that these membrane surfaces are enriched with cholesterol as well as PI4P lipid. Normally, cholesterol regulates membrane fluidity and elasticity, generating domains to sequester proteins so they can interact effectively.

Altan-Bonnet said that the PI4P lipid and cholesterol together may generate "sticky" membrane domains that viruses exploit for replication. Since viral proteins are relatively few after they invade the host cell, a "sticky" rallying point could be critical to their survival.

The researchers also discovered that RNA polymerases, which are vital for synthesizing the nucleic acids of viruses, have specific binding sites that lock onto PI4P lipids.

Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our infectious diseases / bacteria / viruses section for the latest news on this subject. This research was supported by grants from the National Science Foundation and the National Institutes of Health.
AUTHOR PRESENTS: "Viral interior design: Rewiring the host to generate organelle platforms for replication," Wed., Dec. 7, 2011, 10:15 a.m. to 10:35 a.m., during Minisymposium: Cell-Pathogen Interactions (Viruses and Bacteria) Presentation: 180 Room: 605
American Society for Cell Biology Please use one of the following formats to cite this article in your essay, paper or report:

MLA

American Society for Cell Biology. "Lipid-Modifying Enzyme: New Target For Pan-Viral Therapeutics." Medical News Today. MediLexicon, Intl., 8 Dec. 2011. Web.
8 Dec. 2011. APA

Please note: If no author information is provided, the source is cited instead.


Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



View the original article here